Mounjaro 5mg: the dose that tells you whether treatment is working

5mg is the first full therapeutic dose of tirzepatide, reached after four weeks on the 2.5mg tolerability pen.
Each 5mg KwikPen contains four weekly doses; the pen is stored in the fridge between uses.
At 5mg, tirzepatide activates both GIP and GLP-1 receptors, slowing gastric emptying and reducing appetite more noticeably than at 2.5mg.
Titration up to 7.5mg, or staying at 5mg longer, is a clinical decision based on how you are tolerating the current dose and how treatment is progressing.

Mounjaro 5mg is the second strength in the tirzepatide schedule, taken once weekly after a month on the 2.5mg starter pen. By this point the tolerability phase is behind you, and 5mg is where many people begin to notice a meaningful shift in appetite. It is a prescription-only medicine assessed by a clinician before it is prescribed, and the right decision to move to it, stay at it, or step up further is always made with your prescriber rather than by a fixed timeline.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Making sense of the 5mg decision: when to stay, when to step up, and what to expect along the way

Why 5mg is a different conversation from 2.5mg

The 2.5mg pen has one job: to let your body adjust. Side effects are usually mildest there, and that is deliberate. The dose is set low precisely so the gastrointestinal system has time to adapt before tirzepatide is doing much therapeutically.

At 5mg, the picture shifts. You are now at the first dose where meaningful appetite suppression is expected. Most people find they feel full sooner at meals, feel less driven to snack between them, and think about food differently. That is tirzepatide working as a dual GIP and GLP-1 receptor agonist, influencing two gut-hormone pathways at once — something no other licensed weight-management injection in the UK does. The NHS tirzepatide medicines page gives a plain-English account of how the drug works if you want the mechanism explained simply.

It is also worth being honest about something: arriving at 5mg can feel like a test of patience. You have spent a month on a dose that was never designed to produce dramatic change, and it is completely normal to feel uncertain whether it is doing anything. The shift that comes at 5mg is usually the first concrete sign that it is.

Side effects at 5mg are broadly similar in character to those at 2.5mg (nausea, loose stools, constipation and indigestion are the most common) but can be more noticeable. They typically settle within the first week or two at the new dose. If they do not, that is a conversation for your prescriber before any further increase is considered.

Whether to stay at 5mg or move to 7.5mg

This is the decision most people are actually trying to make when they search for information about this dose. The honest answer is that it depends on two things: how well you are tolerating 5mg, and what your prescriber sees in your progress.

Clinically, the schedule allows a step up to 7.5mg after four weeks at 5mg, but that step is not automatic. If side effects are still pronounced at week four, staying at 5mg for another four weeks is a reasonable clinical choice. If appetite control feels adequate and you are losing weight at a pace your prescriber considers appropriate, there may be no urgency to increase. If progress has slowed and tolerance is good, stepping up makes sense. All of that is assessed individually.

Some people remain at 5mg for longer than the minimum and do well. Others find they need the higher strengths to reach the results they are aiming for. The 5mg dose in the context of the full titration schedule is covered in more detail if you want to understand how the steps fit together.

For context on what the full treatment journey can look like, including the higher doses, the weight-loss treatment overview sets out how the programme works in practice at nume.

Cost and the single transparent price

Questions about Mounjaro 5mg pricing are common, and the picture has changed since Eli Lilly revised its UK list price from September 2025. Private prices for the 5mg pen vary between providers. What is worth checking is what any quoted price actually includes: some headline figures exclude the consultation, the prescription, delivery, and any aftercare if side effects arise.

The NICE tirzepatide appraisal, TA1026, sets out the NHS eligibility criteria for tirzepatide, which are currently more restrictive than private licensing thresholds and are being phased in gradually. For people who do not yet meet NHS criteria, or who prefer not to wait, a private route through a registered online pharmacy is the practical alternative. It is also worth knowing that tirzepatide 80 mg represents the upper end of what the treatment schedule can involve, which gives a sense of the full range of the programme.

At nume, one price covers the consultation, the prescription fee, the medication, and free next-working-day tracked delivery. There are no subscriptions and no surprise charges. Every repeat order is reviewed clinically before it is approved, which matters at a dose-increase stage especially.

What happens when you reach 5mg at a GPhC-registered pharmacy

Moving to 5mg requires clinical review of your progress and your tolerance of the previous dose. At a legitimate online pharmacy, that review is carried out by a qualified prescriber looking at your actual responses — not an automated check. Our clinical team reviews every dose step personally, the same day, before anything is dispatched.

If you are transferring from another provider and are already on 5mg, you will need to provide evidence of your current treatment. That is a GPhC guidance requirement, and any regulated pharmacy should ask for it. If one does not, that is worth noting. The GPhC pharmacy register lets you verify any online pharmacy in seconds, it is the clearest signal that a service is operating within UK law.

Missed doses, what to do if injection day falls on a travel day, pen storage once it is out of the fridge, all of that is covered in the patient information leaflet that comes with your pen, and any clinical question outside those basics is best directed to your prescriber. Our aftercare team is available seven days a week for exactly that.

If you would like a clinician to review whether 5mg is the right next step for you, or whether you are ready to consider stepping up from it, you are welcome to speak to our prescribers, there is no charge for the consultation.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions